Paul Michael Armistead MD PhD
Hematologic Oncology
Associate Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Join to View Full Profile
101 Manning DrChapel Hill, NC 27599
Phone+1 919-966-4131
Dr. Armistead is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Stem cell transplant and cellular therapy
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2005 - 2008
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
University of North Carolina at Chapel Hill School of MedicineClass of 2002
Certifications & Licensure
NC State Medical License 2008 - 2025
TX State Medical License 2005 - 2010
MA State Medical License 2004 - 2005
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients Start of enrollment: 2018 Mar 01
Publications & Presentations
PubMed
- The Prevalence of Multidrug Resistance in Enterobacterales Is Higher in Patients Undergoing Hematopoietic Stem Cell Transplantation.Tessa M Andermann, Dylan Brown, Thomas Holowka, Luther A Bartelt, Jonathan S Serody
Open Forum Infectious Diseases. 2025-01-01 - 7 citationsSARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou
Clinical Infectious Diseases. 2024-08-16 - 55 citationsKilling tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses.Menglin Wang, Benoit Rousseau, Kunyu Qiu, Guannan Huang, Yu Zhang
Nature Biotechnology. 2024-08-01
Press Mentions
Press Ganey Recognizes UNC Health in 2024 Human Experience AwardsJanuary 29th, 2025- North Carolina 6-Year-Old Searching for Bone Marrow DonorDecember 11th, 2024
- Could Baking Soda Fight Leukemia Relapse After Stem Cell Transplant?January 5th, 2021
- Join now to see all
Grant Support
- MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIAUNIVERSITY OF WASHINGTON2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
